Aberrant activation of AKT in cancer may occur via several mechanisms including mutational activation of the catalytic subunit of PI3K, which generates PIP3 and, indirectly, PI3,4P2; loss of the PIP3 phosphatase PTEN; and, albeit less frequently, activating mutations in AKT4. The gene discussed is AKT1; the disease is cancer.